ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS)

Q: What does CUSIP 76090R309 represent in this 13F holders report?

CUSIP 76090R309 is the security identifier for RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share in Q3 2024?

8 institutional investors reported RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 76090R309

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 3,326,711
Total 13F shares: 1,263
Share change: +675
Total reported value: $7,137
Price per share: $5.88
Number of holders: 8
Value change: +$3,815
Number of buys: 7

Quarterly Holders Quick Answers

What is CUSIP 76090R309?
CUSIP 76090R309 identifies RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2024

Recent filing periods for CUSIP 76090R309:

Q2 2025 Q1 2025 Q4 2024 Q3 2024

Top shareholders of RSLS - ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	3/4/5	10%+ Owner	— class O/S missing	14,446,692	$79,167,872	—	28 Jun 2021	3/4/5
Yair Schneid	3/4/5	10%+ Owner	— class O/S missing	2,461,000	$13,486,280	—	05 Jan 2024	3/4/5
Barton P. Bandy	3/4/5	President and CEO, Director	— class O/S missing	773,098	$208,736	—	05 Aug 2022	3/4/5
Dan W. Gladney	3/4/5	Director	— class O/S missing	283,922	$76,659	—	22 Jul 2021	3/4/5
Arda Minocherhomjee PhD	3/4/5	Director	— class O/S missing	253,429	$68,426	—	22 Jul 2021	3/4/5
BLACKFORD GARY	3/4/5	Director	— class O/S missing	253,429	$68,426	—	22 Jul 2021	3/4/5
Lori Courtney McDougal	3/4/5	Director	— class O/S missing	253,429	$68,426	—	22 Jul 2021	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	132,566	$25,399	—	30 Jun 2024	13F
Thomas Stankovich	3/4/5	Chief Financial Officer	— class O/S missing	45,726	$11,890	—	30 Nov 2023	3/4/5
UBS Group AG	13F	Company	— class O/S missing	57,751	$11,088	—	30 Jun 2024	13F
Virtu Financial LLC	13F	Company	— class O/S missing	58,913	$11,000	—	30 Jun 2024	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	49,874	$9,556	—	30 Jun 2024	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	34,060	$6,526	—	30 Jun 2024	13F
HRT FINANCIAL LP	13F	Company	— class O/S missing	19,646	$3,000	—	30 Jun 2024	13F
STATE STREET CORP	13F	Company	— class O/S missing	13,015	$2,494	—	30 Jun 2024	13F
XTX Topco Ltd	13F	Company	— class O/S missing	12,486	$2,392	—	30 Jun 2024	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	9,192	$1,765	—	30 Jun 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	— class O/S missing	192	$37	—	30 Jun 2024	13F
Cornerstone Planning Group LLC	13F	Company	— class O/S missing	135	$24	—	30 Jun 2024	13F
Qube Research & Technologies Ltd	13F	Company	— class O/S missing	100	$19	—	30 Jun 2024	13F
GROUP ONE TRADING LLC	13F	Company	— class O/S missing	3	$1	—	30 Jun 2024	13F

Institutional Holders of ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) as of Q3 2024

As of 30 Sep 2024, ReShape Lifesciences Inc. - Common Stock, par value $0.001 per share (RSLS) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,263 shares. The largest 9 holders included Tower Research Capital LLC (TRC), BlackRock, Inc., BANK OF AMERICA CORP /DE/, GROUP ONE TRADING LLC, DANSKE BANK A/S, JPMORGAN CHASE & CO, CIBC Private Wealth Group LLC, MORGAN STANLEY, and UBS Group AG. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2024 vs Q1 2025 Across Filers

Q1 2025 holders

Q3 2024 holders

Holder diff

-1

Investor	Q1 2025 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q3 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.